DINGDANG HEALTH (09886) Income Statement & Earnings

1.050
+0.010+0.96%

Not Open Apr 27 16:06 CST

1.39BMarket Cap-25.61P/E (TTM)

DINGDANG HEALTH (09886) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Turnover

4.68%4.89B

2.60%2.33B

-3.87%4.67B

0.92%2.27B

12.19%4.86B

12.94%2.25B

17.68%4.33B

--1.99B

26.64%987.41M

65.07%3.68B

Operating income

4.68%4.89B

2.60%2.33B

-3.87%4.67B

0.92%2.27B

12.19%4.86B

12.94%2.25B

17.68%4.33B

1.99B

26.64%987.41M

65.07%3.68B

Cost of sales

-1.07%-3.16B

0.33%-1.51B

6.44%-3.13B

3.08%-1.52B

-16.21%-3.35B

-18.06%-1.56B

-14.43%-2.88B

---1.33B

-20.30%-652.99M

-72.08%-2.52B

Operating expenses

-1.07%-3.16B

0.33%-1.51B

6.44%-3.13B

3.08%-1.52B

-16.21%-3.35B

-18.06%-1.56B

-14.43%-2.88B

-1.33B

-20.30%-652.99M

-72.08%-2.52B

Gross profit

12.04%1.72B

8.52%815.81M

1.83%1.54B

10.08%751.74M

4.21%1.51B

2.74%682.91M

24.72%1.45B

664.67M

41.15%334.42M

51.70%1.16B

Selling expenses

-8.50%-1.1B

-8.23%-525.88M

-4.17%-1.01B

-4.45%-485.87M

-7.10%-972.71M

-10.78%-465.16M

-8.80%-908.24M

---419.91M

-31.24%-208.77M

-89.16%-834.78M

Administrative expenses

24.44%-173.57M

19.31%-101.74M

11.19%-229.71M

1.31%-126.09M

22.68%-258.66M

38.14%-127.76M

30.49%-334.52M

---206.52M

-158.10%-100.69M

-297.84%-481.26M

Research and development expenses

11.14%-54.37M

-2.62%-24.99M

5.84%-61.19M

20.60%-24.36M

26.95%-64.98M

33.56%-30.68M

7.50%-88.95M

---46.17M

-16.13%-22.64M

-17.17%-96.16M

Revaluation surplus

----

-174.56%-2.5B

---362.46M

58.08%-280.62M

-20.89%-912.2M

-Changes in the fair value of other assets

----

-174.56%-2.5B

---362.46M

58.08%-280.62M

-20.89%-912.2M

Impairment and provision

99.56%-923K

69.21%-677K

-58,248.60%-207.72M

-331.47%-2.2M

76.97%-356K

276.58%950K

-483.40%-1.55M

---538K

-87.56%-1.12M

91.60%-265K

-Impairment of intangible assets

----

---6.85M

----

-Goodwill impairment

----

---198.92M

----

-Other impairment is provision

52.88%-923K

69.21%-677K

-450.28%-1.96M

-331.47%-2.2M

76.97%-356K

276.58%950K

-483.40%-1.55M

---538K

-87.56%-1.12M

91.60%-265K

Operating interest expense

----

---3.84M

4.31%-1.95M

----

Special items of operating profit

-7.11%-413.62M

-5.17%-201.25M

9.11%-386.15M

-12.74%-191.36M

2.58%-424.86M

17.91%-169.73M

-8.56%-436.1M

---206.75M

-28.19%-109.33M

-58.95%-401.73M

Operating profit

94.90%-18.34M

50.43%-38.73M

-70.54%-359.67M

28.62%-78.14M

92.53%-210.9M

81.18%-109.47M

-80.57%-2.82B

-581.52M

47.06%-390.69M

-74.82%-1.56B

Financing cost

-39.25%-12.38M

-26.78%-5.52M

-12.84%-8.89M

-10.77%-4.35M

0.49%-7.88M

---3.93M

55.46%-7.92M

----

---17.78M

Share of profits of associates

----

36.40%-1.56M

-402.99%-1.18M

---2.45M

---234K

----

Special items of earning before tax

----

-57.01%-11.4M

----

Earning before tax

91.70%-30.72M

47.11%-44.25M

-67.30%-370.12M

26.37%-83.66M

92.19%-221.23M

80.46%-113.63M

-79.04%-2.83B

-581.52M

46.04%-402.09M

-75.59%-1.58B

Tax

-116.83%-21.4M

-26.69%-7.78M

-2.34%-9.87M

-65.02%-6.14M

4.81%-9.64M

15.36%-3.72M

40.82%-10.13M

---4.39M

37.34%-2.33M

8.93%-17.12M

After-tax profit from continuing operations

86.29%-52.11M

42.07%-52.02M

-64.59%-379.99M

23.48%-89.8M

91.88%-230.87M

79.97%-117.35M

-77.76%-2.84B

-585.91M

46.00%-404.42M

-73.86%-1.6B

Earning after tax

86.29%-52.11M

42.07%-52.02M

-64.59%-379.99M

23.48%-89.8M

91.88%-230.87M

79.97%-117.35M

-77.76%-2.84B

-585.91M

46.00%-404.42M

-73.86%-1.6B

Minority profit

11.32%-3.09M

93.41%-350K

31.05%-3.49M

-11.16%-5.31M

43.03%-5.06M

39.10%-4.78M

57.61%-8.88M

---7.84M

-23.20%-5.55M

-558.38%-20.95M

Profit attributable to shareholders

86.98%-49.02M

38.84%-51.67M

-66.73%-376.5M

24.95%-84.49M

92.03%-225.81M

80.53%-112.57M

-79.55%-2.83B

-578.07M

46.42%-398.86M

-70.74%-1.58B

Basic earnings per share

85.71%-0.04

33.33%-0.04

-64.71%-0.28

25.00%-0.06

94.96%-0.17

91.30%-0.08

-1.81%-3.37

-0.92

78.42%-0.63

8.56%-3.31

Diluted earnings per share

85.71%-0.04

33.33%-0.04

-64.71%-0.28

25.00%-0.06

94.96%-0.17

91.30%-0.08

-1.81%-3.37

-0.92

78.42%-0.63

8.56%-3.31

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Touche Tohmatsu会计师事务所

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Turnover	4.68%4.89B	2.60%2.33B	-3.87%4.67B	0.92%2.27B	12.19%4.86B	12.94%2.25B	17.68%4.33B	--1.99B	26.64%987.41M	65.07%3.68B
Operating income	4.68%4.89B	2.60%2.33B	-3.87%4.67B	0.92%2.27B	12.19%4.86B	12.94%2.25B	17.68%4.33B	1.99B	26.64%987.41M	65.07%3.68B
Cost of sales	-1.07%-3.16B	0.33%-1.51B	6.44%-3.13B	3.08%-1.52B	-16.21%-3.35B	-18.06%-1.56B	-14.43%-2.88B	---1.33B	-20.30%-652.99M	-72.08%-2.52B
Operating expenses	-1.07%-3.16B	0.33%-1.51B	6.44%-3.13B	3.08%-1.52B	-16.21%-3.35B	-18.06%-1.56B	-14.43%-2.88B	-1.33B	-20.30%-652.99M	-72.08%-2.52B
Gross profit	12.04%1.72B	8.52%815.81M	1.83%1.54B	10.08%751.74M	4.21%1.51B	2.74%682.91M	24.72%1.45B	664.67M	41.15%334.42M	51.70%1.16B
Selling expenses	-8.50%-1.1B	-8.23%-525.88M	-4.17%-1.01B	-4.45%-485.87M	-7.10%-972.71M	-10.78%-465.16M	-8.80%-908.24M	---419.91M	-31.24%-208.77M	-89.16%-834.78M
Administrative expenses	24.44%-173.57M	19.31%-101.74M	11.19%-229.71M	1.31%-126.09M	22.68%-258.66M	38.14%-127.76M	30.49%-334.52M	---206.52M	-158.10%-100.69M	-297.84%-481.26M
Research and development expenses	11.14%-54.37M	-2.62%-24.99M	5.84%-61.19M	20.60%-24.36M	26.95%-64.98M	33.56%-30.68M	7.50%-88.95M	---46.17M	-16.13%-22.64M	-17.17%-96.16M
Revaluation surplus	----	----	----	----	----	----	-174.56%-2.5B	---362.46M	58.08%-280.62M	-20.89%-912.2M
-Changes in the fair value of other assets	----	----	----	----	----	----	-174.56%-2.5B	---362.46M	58.08%-280.62M	-20.89%-912.2M
Impairment and provision	99.56%-923K	69.21%-677K	-58,248.60%-207.72M	-331.47%-2.2M	76.97%-356K	276.58%950K	-483.40%-1.55M	---538K	-87.56%-1.12M	91.60%-265K
-Impairment of intangible assets	----	----	---6.85M	----	----	----	----	----	----	----
-Goodwill impairment	----	----	---198.92M	----	----	----	----	----	----	----
-Other impairment is provision	52.88%-923K	69.21%-677K	-450.28%-1.96M	-331.47%-2.2M	76.97%-356K	276.58%950K	-483.40%-1.55M	---538K	-87.56%-1.12M	91.60%-265K
Operating interest expense	----	----	----	----	----	----	----	---3.84M	4.31%-1.95M	----
Special items of operating profit	-7.11%-413.62M	-5.17%-201.25M	9.11%-386.15M	-12.74%-191.36M	2.58%-424.86M	17.91%-169.73M	-8.56%-436.1M	---206.75M	-28.19%-109.33M	-58.95%-401.73M
Operating profit	94.90%-18.34M	50.43%-38.73M	-70.54%-359.67M	28.62%-78.14M	92.53%-210.9M	81.18%-109.47M	-80.57%-2.82B	-581.52M	47.06%-390.69M	-74.82%-1.56B
Financing cost	-39.25%-12.38M	-26.78%-5.52M	-12.84%-8.89M	-10.77%-4.35M	0.49%-7.88M	---3.93M	55.46%-7.92M	----	----	---17.78M
Share of profits of associates	----	----	36.40%-1.56M	-402.99%-1.18M	---2.45M	---234K	----	----	----	----
Special items of earning before tax	----	----	----	----	----	----	----	----	-57.01%-11.4M	----
Earning before tax	91.70%-30.72M	47.11%-44.25M	-67.30%-370.12M	26.37%-83.66M	92.19%-221.23M	80.46%-113.63M	-79.04%-2.83B	-581.52M	46.04%-402.09M	-75.59%-1.58B
Tax	-116.83%-21.4M	-26.69%-7.78M	-2.34%-9.87M	-65.02%-6.14M	4.81%-9.64M	15.36%-3.72M	40.82%-10.13M	---4.39M	37.34%-2.33M	8.93%-17.12M
After-tax profit from continuing operations	86.29%-52.11M	42.07%-52.02M	-64.59%-379.99M	23.48%-89.8M	91.88%-230.87M	79.97%-117.35M	-77.76%-2.84B	-585.91M	46.00%-404.42M	-73.86%-1.6B
Earning after tax	86.29%-52.11M	42.07%-52.02M	-64.59%-379.99M	23.48%-89.8M	91.88%-230.87M	79.97%-117.35M	-77.76%-2.84B	-585.91M	46.00%-404.42M	-73.86%-1.6B
Minority profit	11.32%-3.09M	93.41%-350K	31.05%-3.49M	-11.16%-5.31M	43.03%-5.06M	39.10%-4.78M	57.61%-8.88M	---7.84M	-23.20%-5.55M	-558.38%-20.95M
Profit attributable to shareholders	86.98%-49.02M	38.84%-51.67M	-66.73%-376.5M	24.95%-84.49M	92.03%-225.81M	80.53%-112.57M	-79.55%-2.83B	-578.07M	46.42%-398.86M	-70.74%-1.58B
Basic earnings per share	85.71%-0.04	33.33%-0.04	-64.71%-0.28	25.00%-0.06	94.96%-0.17	91.30%-0.08	-1.81%-3.37	-0.92	78.42%-0.63	8.56%-3.31
Diluted earnings per share	85.71%-0.04	33.33%-0.04	-64.71%-0.28	25.00%-0.06	94.96%-0.17	91.30%-0.08	-1.81%-3.37	-0.92	78.42%-0.63	8.56%-3.31
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--	Unqualified Opinion
Auditor	--	--	Deloitte Touche Tohmatsu会计师事务所	--	Deloitte Touche Tohmatsu会计师事务所	--	Deloitte Touche Tohmatsu会计师事务所	--	--	Deloitte Touche Tohmatsu会计师事务所

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"